2 Results for "

ORIC-114

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "ORIC-114" in MCE Product Catalog:

Cat. No.: HY-172429
CAS No.: 2489185-38-6
Synonyms: ORIC-114
Target:  

EGFR

Research Areas:  

Neurological Disease Cancer

Enozertinib (ORIC-114) is an orally active, CNS-penetrant, highly selective and irreversible dual EGFR/HER2 inhibitor that exhibits potent and targeted inhibition of exon 20 insertion mutations. Enozertinib exhibits high kinome selectivity for the EGFR family of receptors to reduce off-target kinase liabilities. Enozertinib induces tumor regression and demonstrates antitumor activity in central nervous system and non-small cell lung cancer (NSCLC) tumor models. Enozertinib can be used for the research of solid tumors and NSCLC .
loading...
    loading...
Cat. No.: HY-172429A
Synonyms: ORIC-114 hemihydrate
Target:  

EGFR

Research Areas:  

Neurological Disease Cancer

Enozertinib (ORIC-114) hemihydrate is an orally active, CNS-penetrant, highly selective and irreversible dual EGFR/HER2 inhibitor that exhibits potent and targeted inhibition of exon 20 insertion mutations. Enozertinib hemihydrate exhibits high kinome selectivity for the EGFR family of receptors to reduce off-target kinase liabilities. Enozertinib hemihydrate induces tumor regression and demonstrates antitumor activity in central nervous system and non-small cell lung cancer (NSCLC) tumor models. Enozertinib hemihydrate can be used for the research of solid tumors and NSCLC .
loading...
    loading...